Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-01

Clinical Trial Update: Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease

View source ↗

Summary

A completed clinical trial investigating the relationship between inflammatory markers and adverse outcomes in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Kidney Lifescience Technologies | Conditions: Chronic Kidney Disease | Status: COMPLETED